ReviewClinical optometry2020
A Review of Hypertensive Retinopathy and Chorioretinopathy.
Review in Clinical optometry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.
- The Application of Optical Coherence Tomography Angiography in Systemic Hypertension: A Meta-Analysis.Frontiers in medicine · 2021Pooled it
- Adaptive Optics RTX1 Imaging for Early Detection of Retinal Vascular Remodeling in Hypertensive Retinopathy: A Review.Journal of clinical medicine · 2026Review
- Article
- Association of diurnal blood pressure patterns with heart rate variability and retinopathy in patients with essential hypertension.Scientific reports · 2026Article
- Rhabdomyolysis, Acute Kidney Injury, and Exudative Retinal Detachment Associated with Nonsteroidal Anti-Inflammatory Drug and Herbal Product Use: A Case Report.Journal of clinical practice and research · 2026Article
- Multimodal Imaging of Yellow-White Transformation in Chorioretinal Hemorrhages: Structural and Biochemical Insights.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Bilateral vision loss as first clinical manifestation of IgA nephropathy.BMC ophthalmology · 2025Article
- Hypertensive retinopathy: The need for a change in perspective.Indian journal of ophthalmology · 2025Article
- Plant-Derived Exosome-Coated Niosome Oxygen Nanobubbles for the Mitigation of Ocular Ischemia.ACS pharmacology & translational science · 2025Article
- Altered retinal vasculature in childhood cancer survivors: Data from the German CVSS-study.Acta ophthalmologica · 2025Article
- Artificial intelligence in managing retinal disease-current concepts and relevant aspects for health care providers.Wiener medizinische Wochenschrift (1946) · 2025Review
- Bilateral choroidal detachment: A novel feature of hypertensive chorioretinopathy in a 26-year-old man with end-stage renal disease.American journal of ophthalmology case reports · 2025Article
- Prevalence of hypertensive retinopathy and its associated factors among adult hypertensive patients attending at Comprehensive Specialized Hospitals in Northwest Ethiopia, 2024, a multicenter cross-sectional study.International journal of retina and vitreous · 2025Article
- Alterations of interhemispheric functional connectivity in patients with hypertensive retinopathy using voxel-mirrored homotopic connectivity: a resting state fMRI study.International journal of ophthalmology · 2025Article
- Hypertensive Choroidopathy With Bilateral Serous Retinal Detachment as the Presenting Finding in Malignant Hypertension.Case reports in ophthalmological medicine · 2025Article
- Bilateral Idiopathic Neuroretinitis.Diagnostics (Basel, Switzerland) · 2024Article
- Hypertensive Retinopathy among Hypertensive Patients in a Tertiary Care Centre: A Descriptive Cross-sectional Study.JNMA; journal of the Nepal Medical Association · 2024Article
- Optical Coherence Tomography Angiography Findings Associated With Accelerated Hypertension.Cureus · 2024Article
- Artificial Intelligence (AI) for Early Diagnosis of Retinal Diseases.Medicina (Kaunas, Lithuania) · 2024Review
- Fucoidan modulates SIRT1 and NLRP3 to alleviate hypertensive retinopathy: in vivo and in vitro insights.Journal of translational medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertensive retinopathy and choroidopathy have important short- and long-term implications on patients' overall health and mortality. Eye care professionals should be familiar with the severity staging of these entities and be able to readily recognize and refer patients who are in need of systemic blood pressure control. This paper will review the diagnosis, staging, treatment, and long-term implications for vision and mortality of patients with hypertensive retinopathy and choroidopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.